陳SIR陳少雄在1992年成為亞洲電視最年輕既導演,94年離開,正式設立自己既廣告公司,97年自資拍攝兼做主持人的勵志電視節目於亞視播放至2007年,再而轉形復康領域既發展;2004年開始主持於亞視逢星期六、日播出的長者健康節目,直至2014年完結。其後全心發展領域的研究與開發直至目前。
我們於2009年已與上海交通大學香港全資子公司組成合資公司，開發交大的；於2012年與廣州的雅敦醫療集團成立了合資公司，順利引入了美國的腫瘤醫療技術到東南亞眾多大型的教學醫院，例如：
中國大陸：
北京301、北京瑞金醫院、北京協和醫院、復旦大學腫瘤醫院、中山大學腫瘤防治中心、中山大學附屬第一醫院、中山大學附屬第二醫院……
香港：威爾斯親王醫院、法國醫院、浸信會醫院……
臺灣地區：臺灣大學醫院……
新加坡：國
立大學醫院、陳督生醫院、ParkWay私立醫院……
2021年，我們更已成功簽署新一代氬氦刀（腫瘤冷凍消融科技）的東南亞多國獨家代理權，希望更快鋪開到東南亞各大醫院，使更多合適的不幸病患者能更早接受此科技帶來的生命新曙光！
鑒於在國際醫療嶺域的多年經營活動，科學+家與眾多海內外的專科醫院、醫生建立了良好的合作關係，而不同國家地區的醫院醫生均有不同的專長，我們能够為帶患提供更佳的醫療選擇及安排。
In 2009, we have formed a joint venture with a wholly-owned subsidiary of Shanghai Jiaotong University in Hong Kong to develop the of Jiaotong University; In 2012, a joint venture was established with Acton medical group in Guangzhou, and the U.S. 'Nanoknife tumor medical technology was successfully introduced to many large hospitals in Southeast Asia, such as:
Mainland China:
Beijing 301, Beijing Ruijin Hospital, Beijing Union Hospital, Fudan University Cancer Hospital, Zhongshan University Cancer Prevention and control center, Zhongshan University Affiliated First Hospital, Zhongshan University Affiliated Second Hospital
Hong Kong: Prince Wales Hospital, St. Teresa's Hospital, Baptist Hospital
Taiwan: Taiwan University Hospital
Singapore: National University Hospital, Chendusheng hospital, Parkway private hospital
In 2021, we have successfully signed the exclusive agency of a new generation of Tumor cryoablation Technology in Southeast Asia. We hope to expand to the major hospitals in Southeast Asia faster, so that more suitable and unfortunate patients can accept the new dawn of life brought by this technology earlier! In view of the years of business activities in the international medical ridge, Scientiist Home has established a good cooperative relationship with many specialized hospitals and doctors at home and abroad. However, different countries and regions of hospital doctors have different expertise, so we can provide better medical choices and arrangements for patients.
